These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17598192)

  • 1. FDA notifications. FDA tentatively approves 3-drug tablet in India.
    AIDS Alert; 2007 Apr; 22(4):43. PubMed ID: 17598192
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA notifications. Fixed combination tablet approved.
    AIDS Alert; 2010 Nov; 25(11):130. PubMed ID: 21128356
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
    AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA approves two combination pills, Epzicom and Truvada; comment on commercial race to once-a-day nucleosides.
    James JS
    AIDS Treat News; 2004 Jul; (403):6. PubMed ID: 15386855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New once-a-day pill submitted to FDA. First complete regimen in single tablet.
    AIDS Alert; 2006 Aug; 21(8):91-2. PubMed ID: 16913043
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA approves two combo brand-name AIDS drugs.
    Med Health; 2004 Aug; 58(31):3-4. PubMed ID: 15368717
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA notifications. FDA tentatively approves generic lamivudine.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580368
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA notifications. Adult treatment guidelines updated.
    AIDS Alert; 2005 Nov; 20(11):130-1. PubMed ID: 16363050
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA notifications. FDA tentatively approves generic atazanavir.
    AIDS Alert; 2008 Mar; 23(3):32. PubMed ID: 18661639
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA notifications. Changes to ART guidelines detailed by the FDA.
    AIDS Alert; 2008 Mar; 23(3):33-4. PubMed ID: 18663777
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA notifications. FDA provides important information for clinicians serving hurricane victims.
    AIDS Alert; 2005 Nov; 20(11):129. PubMed ID: 16363049
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA notifications. Tentative approval granted for combo antiretroviral drug.
    AIDS Alert; 2007 Oct; 22(10):117-8. PubMed ID: 18416009
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA notifications. FDA grants approval for raltegravir.
    AIDS Alert; 2009 Apr; 24(4):46-8. PubMed ID: 19382366
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA notifications. Pediatric HIV infection guidelines for use of ARTs are revised.
    AIDS Alert; 2008 Apr; 23(4):46-7. PubMed ID: 19255980
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. Lamivudine/zidovudine tab tentatively approved.
    AIDS Alert; 2009 Jul; 24(7):83-4. PubMed ID: 19705579
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA notifications. FDA gives tentative approval for stavudine, lamivudine & nevirapine tablet.
    AIDS Alert; 2009 Sep; 24(9):105-6. PubMed ID: 19938312
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA notifications. FDA published 2 new rules regarding INDs.
    AIDS Alert; 2009 Nov; 24(11):130-1. PubMed ID: 19967790
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA notifications. Revised guidelines for pregnant women.
    AIDS Alert; 2007 Dec; 22(12):141. PubMed ID: 18411483
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA notifications. FDA approves half-strength Kaletra.
    AIDS Alert; 2008 Jan; 23(1):10. PubMed ID: 18572474
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA notifications. FDA approves NAT for HIV screening.
    AIDS Alert; 2007 Jul; 22(7):79-80. PubMed ID: 17768777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.